PFBT
FATE icon

Parkside Financial Bank & Trust’s Fate Therapeutics FATE Stock Holding History

Parkside Financial Bank & Trust’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$804 Hold
670
– – ﹤0.01% 2428
2025
Q4 		$659 Hold
670
– – ﹤0.01% 2488
2025
Q3 		$845 Hold
670
– – ﹤0.01% 2357
2025
Q2 		$751 Buy
+670
New +$779 ﹤0.01% 2358

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parkside Financial Bank & Trust's FATE Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Fate Therapeutics (FATE) position steady in Q1 2026 at 670 shares worth $804. The position accounts for ﹤0.01% of the portfolio, ranked #2428.

Parkside Financial Bank & Trust first reported a position in FATE in Q2 2025 and has held it in 4 quarters since. The position peaked at $845 in Q3 2025. 157 funds tracked by Wall St. Rank hold FATE as of Q1 2026.

  • Parkside Financial Bank & Trust held 670 shares of Fate Therapeutics worth $804 as of Q1 2026.
  • Parkside Financial Bank & Trust left its Fate Therapeutics share count unchanged in Q1 2026.
  • Fate Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2428 holding.
  • Parkside Financial Bank & Trust first reported a position in Fate Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Parkside Financial Bank & Trust's Fate Therapeutics position peaked at $845 in Q3 2025.
  • 157 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.